Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial)

NCT05909683 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Sepsis

Interventions

DIAGNOSTIC_TEST: Change of antimicrobials based on BCID2 and Reveal Rapid AST tests. Stop of antimicrobials based on PCT results.
OTHER: Standard of Care

Sponsor

Hellenic Institute for the Study of Sepsis